Dana Investment Advisors, Inc. Repligen Corp Transaction History

Dana Investment Advisors, Inc.

$2.99 Billion
Q3 2024

A detailed history of Dana Investment Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 5,707 shares of RGEN stock, worth $812,848. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,707

Previous 6,071 6.0%

Holding current value

$812,848

Previous $765,000 10.98%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.79 - $167.35 $43,603 - $60,915	-364 Reduced 6.0%	5,707 $849,000
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $228,360 - $348,153	1,903 Added 45.66%	6,071 $765,000
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $51,917 - $63,359	304 Added 7.87%	4,168 $766,000
Q4 2023 Feb 07, 2024	SELL	$114.17 - $185.35 $65,419 - $106,205	-573 Reduced 12.91%	3,864 $694,000
Q3 2023 Nov 15, 2023	SELL	$138.78 - $176.51 $353,333 - $449,394	-2,546 Reduced 36.46%	4,437 $705,000
Q2 2023 Aug 15, 2023	BUY	$138.42 - $180.31 $213,028 - $277,497	1,539 Added 28.27%	6,983 $987,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $118,934 - $152,735	-771 Reduced 12.41%	5,444 $916,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $9,582 - $13,013	-59 Reduced 0.94%	6,215 $1.05 Million
Q3 2022 Nov 15, 2022	SELL	$160.42 - $256.21 $61,761 - $98,640	-385 Reduced 5.78%	6,274 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $18,991 - $25,382	-135 Reduced 1.99%	6,659 $1.08 Million
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $341,722 - $546,875	2,120 Added 45.36%	6,794 $1.28 Million
Q4 2021 Feb 09, 2022	SELL	$247.59 - $304.47 $27,977 - $34,405	-113 Reduced 2.36%	4,674 $1.24 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $402,200 - $669,493	-2,065 Reduced 30.14%	4,787 $1.38 Million
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $497 - $662	-3 Reduced 0.04%	6,852 $1.37 Million
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $255,403 - $320,384	-1,416 Reduced 17.12%	6,855 $1.33 Million
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $508,358 - $709,154	-3,433 Reduced 29.33%	8,271 $1.59 Million
Q3 2020 Nov 10, 2020	SELL	$122.51 - $158.27 $90,167 - $116,486	-736 Reduced 5.92%	11,704 $1.73 Million
Q2 2020 Aug 11, 2020	SELL	$94.33 - $140.48 $523,531 - $779,664	-5,550 Reduced 30.85%	12,440 $1.54 Million
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $444,765 - $571,347	-5,235 Reduced 22.54%	17,990 $1.74 Million
Q4 2019 Feb 11, 2020	SELL	$73.84 - $93.08 $129,884 - $163,727	-1,759 Reduced 7.04%	23,225 $2.15 Million
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $354,582 - $441,829	-4,626 Reduced 15.62%	24,984 $1.92 Million
Q2 2019 Aug 13, 2019	SELL	$54.2 - $85.95 $141,841 - $224,931	-2,617 Reduced 8.12%	29,610 $2.55 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $1.59 Million - $2.02 Million	32,227 New	32,227 $1.9 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.3M

Call Options Held

350K

Put Options Held

184K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.9B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Repligen Corp Transaction History